14 deals
Life sciences investor MTPConnect injects $12 million into 14 drug and device startups
MTPConnect's government-backed accelerator program has awarded $12.07 million in non-dilutive grants to 14 Australian drug and device companies, which will also receive mentoring and support from partners including CSL and Roche Diagnostics.